Immunomedics (IMMU) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Zeev Hed who wrote (36)	9/19/1996 9:09:00 PM
From: Josh C. Pleasure, M.D.	of 371

Having spoken with Mr. Herron of IMMU, I can now confirm that the pending announcements I alluded to a couple of days ago are in fact pending. Namely, the full scale countrywide roll-out of CEA-Scan and beginning of sales is going to happen very very soon. IMMU is just waiting for Mallinckrodt to give the Press release the go ahead - they want it available all over the country at the time the announcement is made. Secondly, final European approval is also imminent - just a matter of the Euro's finishing paper work. Lastly, phase III trials of CEA scan for breast CA are simply awaiting FDA approval of the study design. This should happen soon. I know that doses of CEA scan were delivered a couple of weeks ago to the medical centers that will be enrolling patients. Also, I would expect that IMMU is very very close to submitting LeukoScan to the FDA for approval. Anecdotally, there was a screw up recently and all data originally sent to IMMU from our hospital was lost. It had to be reprinted from the stored data, but this was accomplished and IMMU has the data - they had to have it FedExed - Gee, I wonder why. Again, I think submission of LeukoScan to fda for approval is very soon.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next